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R. Milner*
University of Chicago Medical Center, Vascular Surgery, 5841 South Maryland Avenue, MC5028, Chicago, IL 60637, USAThe creation and maintenance of permanent dialysis access can
be a very challenging and frustrating problem for physicians and
patients. The ﬁstula ﬁrst paradigm has been well accepted in the
United States. The goal of this project has been to minimize the use
of temporary catheters for hemodialysis access. The decreased use
of catheters has been advocated as a means to reduce catheter-
based infections as well as the development of central venous
stenosis. But, central venous stenosis continues to plague many
dialysis patients and their access surgeons and interventionalists.
Many surgeons will select a lower extremity site for the creation
of permanent dialysis access if there is an upper extremity central
venous stenosis or occlusion. The rationale has been the limited
durability of a central venous angioplasty and stenting as a method
to maintain an upper extremity permanent dialysis access. The
HeRO graft has been proposed as a technology that can overcome
the technical difﬁculties in maintaining an upper extremity access
when a central venous stenosis or occlusion is present.
Gage et al. report on a 4-site review demonstrating the efﬁcacy
of the HeRO graft-tunneled catheter technology for complicated
access patients. The authors report an excellent primary and
secondary patency rate and decreased risk of infection as compared
to a standard tunneled catheter. They also report a high rate of
technical success despite placing catheters in patients with
multiple prior upper extremity access efforts. Finally, they report an
intervention rate of 1.5/year which is very appropriate given this
complex patient population.
I have placed several of the HeRO grafts and ﬁnd the technology
tobeveryuseful indifﬁcult patients. Iwould like tohighlight someof
the limitations frommy perspective that the authors do not explain
in detail in their manuscript. The authors state that the incidenceDOI of original article: 10.1016/j.ejvs.2012.04.011.
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patients as compared to standard grafts or ﬁstulas. This is especially
true in patients with small brachial arteries. I think the large bore
venousoutﬂow(19 Fr) canpredispose to this problem. Evenwhenan
effort is made to create a relatively small arteriotomy, this chal-
lenging problem can still occur. A DRIL procedure is an option, but
can be quite difﬁcult due to the numerous procedures that these
patients have previously undergone.
Another limitation is the central venous disease and the high
medical risk of these patients for general anesthesia. The majority
of patients require general anesthesia for placement of the HeRO
graft. Many dialysis-dependent patients are considered to be high-
risk for general anesthesia and may not be allowed to have this
option for their treatment based on cardiac clearance. In addition,
even if a patient is medically cleared, they may assume the risk of
general anesthesia and then have a central venous stenosis or
occlusion that can not be traversed. Although the authors state that
is a low frequency situation, I believe that treating central venous
disease can be very challenging. I would dislike a situation where
a high-risk patient assumes the risk of general anesthesia and then
can not have a HeRO graft placed.
Overall, I ﬁnd the HeRO technology to be exceptionally useful as
the authors have published in their 4 center experience with this
device. Many dialysis patients are living longer and struggling with
the complications of tunneled catheters and the difﬁculty of
creating permanent access in this situation. The HeRO graft is able
to overcome these issues. I have found steal syndrome, the need for
general anesthesia, and the central venous disease that can not be
traversed as a limitation of the device. But, I would still use the
technology without hesitation in the appropriate patient.ed by Elsevier Ltd. All rights reserved.
